0
Skip to Content
Alliance for a Stronger FDA
About
About Us
Leadership
Members
Join Us
List of Members
Who can Become a Member
Dues Structure
Media
Budget Docs
Contact
Alliance Archives
Join Us
Alliance for a Stronger FDA
About
About Us
Leadership
Members
Join Us
List of Members
Who can Become a Member
Dues Structure
Media
Budget Docs
Contact
Alliance Archives
Join Us
Folder: About
Back
About Us
Leadership
Folder: Members
Back
Join Us
List of Members
Who can Become a Member
Dues Structure
Media
Budget Docs
Contact
Alliance Archives
Join Us
Analysis and Commentary STEVEN GROSSMAN 5/8/21 Analysis and Commentary STEVEN GROSSMAN 5/8/21

FDA Priorities for FY 22

Read More
Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Advocacy at a Glance STEVEN GROSSMAN 4/23/21

Alliance Hill Day Meetings on April 28-29, with Alliance member participation urgently requested. More on Acting FDA Commissioner Woodcock’s meeting with the Alliance.

Read More
Analysis and Commentary STEVEN GROSSMAN 4/16/21 Analysis and Commentary STEVEN GROSSMAN 4/16/21

Highlights from the Past Week

Read More
Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21

The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance.

Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21

Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9.

Read More
Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Advocacy at a Glance STEVEN GROSSMAN 4/3/21

Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released.

Read More
Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Advocacy at a Glance STEVEN GROSSMAN 1/22/21

Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA.

Read More
Analysis and Commentary STEVEN GROSSMAN 9/28/18 Analysis and Commentary STEVEN GROSSMAN 9/28/18

Janet Woodcock on CDER's Needs and Opportunities

Read More
Advocacy at a Glance STEVEN GROSSMAN 9/28/18 Advocacy at a Glance STEVEN GROSSMAN 9/28/18

FDA Appropriations in Limbo and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Advocacy at a Glance STEVEN GROSSMAN 9/7/18

Congress Returns; Appropriations Bills Advance and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 8/31/18 Advocacy at a Glance STEVEN GROSSMAN 8/31/18

Senate Changes in 302(b) Allocations?

Read More
Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Advocacy at a Glance STEVEN GROSSMAN 8/24/18

Senate Finishes Consideration of DoD/Labor-HHS Mini-bus Funding Bill and more

Read More
Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18

Ag/FDA Moves in the Senate

Read More
Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Advocacy at a Glance STEVEN GROSSMAN 8/5/18

Senate Passes FY 19 Ag/FDA Funding as Part of 4-bill Mini-bus

Read More
Advocacy at a Glance STEVEN GROSSMAN 7/27/18 Advocacy at a Glance STEVEN GROSSMAN 7/27/18

Senate Starts, Doesn’t Finish, Mini-bus Including Ag/FDA

Read More
Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18

Key CDER Priorities Need Funding Too

Read More

The Alliance for a Stronger FDA | 918 14th Street, SE, Apt 1 Washington, DC 20003 | cartier@strengthenfda.org | LinkedIn

The Alliance for a Stronger FDA is an independent, not-for-profit 501(c)(4) corporation registered in the state of Maryland. It is not affiliated with the FDA and current FDA employees can not become members of the Alliance. For information from the FDA, please click here. Copyright 2025, Alliance for a Stronger FDA.